Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-10

Clinical Trial Update: Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy [Phase 4]

View source ↗

Summary

A prospective randomized Phase 4 treatment trial for chronic central serous chorioretinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Chronic Central Serous Chorioretinopathy | Phase 4 | Status: COMPLETED